No evidence that COVID-19 vaccines cause sudden cardiac arrest or myocarditis in athletes

A new start­up aims to chal­lenge No­vo Nordisk and Eli Lil­ly’s du­op­oly atop to­day’s mar­ket for obe­si­ty drugs. The start­up Met­sera of­fi­cial­ly launched Thurs­day, an­nounc­ing

Clin­i­cal-stage cell ther­a­py de­vel­op­er Arti­va Bio­ther­a­peu­tics will seek about $116 mil­lion in net pro­ceeds from its pro­posed ini­tial pub­lic of­fer­ing, ac­cord­ing to an up­dat­ed SEC